- Home
- BMRN vs HL Comparison
BMRN vs HL Comparison
Compare BMRN & HL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | HL |
|---|---|---|
| Founded | 1996 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 11.3B |
| IPO Year | 1999 | 2002 |
Fundamental Metrics
Financial Performance| Metric | BMRN | HL |
|---|---|---|
| Price | $66.53 | $20.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 8 |
| Target Price | ★ $88.22 | $21.13 |
| AVG Volume (30 Days) | 2.2M | ★ 35.8M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.09% |
| EPS Growth | N/A | ★ 716.67 |
| EPS | ★ 0.77 | 0.15 |
| Revenue | ★ $1,313,646,000.00 | $645,957,000.00 |
| Revenue This Year | $15.02 | $4.92 |
| Revenue Next Year | $12.23 | N/A |
| P/E Ratio | ★ $86.55 | $140.70 |
| Revenue Growth | 17.62 | ★ 45.63 |
| 52 Week Low | $49.26 | $10.38 |
| 52 Week High | $70.98 | $34.17 |
Technical Indicators
Market Signals| Indicator | BMRN | HL |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 62.90 |
| Support Level | $58.03 | $20.47 |
| Resistance Level | $70.98 | $22.68 |
| Average True Range (ATR) | 1.56 | 1.03 |
| MACD | -0.34 | -0.03 |
| Stochastic Oscillator | 46.31 | 84.92 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About HL Hecla Mining Company
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.